Roth Capital Starts NovaBay Pharmaceuticals (NBY) at Buy
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Roth Capital initiates coverage on NovaBay Pharmaceuticals (NYSE: NBY) with a Buy. PT $3.50.
For more ratings news on NovaBay Pharmaceuticals click here and for the rating history of NovaBay Pharmaceuticals click here.
Shares of NovaBay Pharmaceuticals closed at $0.92 yesterday.
For more ratings news on NovaBay Pharmaceuticals click here and for the rating history of NovaBay Pharmaceuticals click here.
Shares of NovaBay Pharmaceuticals closed at $0.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
